Kim, S. Y., S Hong, Y., K Shim, E., Kong, S., Shin, A., Baek, J. Y., & Jung, K. H. (2013). S-1 plus irinotecan and oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: A prospective phase II study and pharmacogenetic analysis. Nature Publishing Group.
Citación estilo ChicagoKim, S Y., Y. S Hong, E. K Shim, S-Y Kong, A. Shin, J Y. Baek, y K H. Jung. S-1 Plus Irinotecan and Oxaliplatin for the First-line Treatment of Patients With Metastatic Colorectal Cancer: A Prospective Phase II Study and Pharmacogenetic Analysis. Nature Publishing Group, 2013.
Cita MLAKim, S Y., et al. S-1 Plus Irinotecan and Oxaliplatin for the First-line Treatment of Patients With Metastatic Colorectal Cancer: A Prospective Phase II Study and Pharmacogenetic Analysis. Nature Publishing Group, 2013.